Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a comparative study of pharmacokinetic models and correlation with mRECIST criteria.
Martina Vivoda TomšičSotirios BisdasViljem KovačIgor SeršaKatarina Šurlan PopovičPublished in: Cancer imaging : the official publication of the International Cancer Imaging Society (2019)
Both models show potential in predicting response to therapy in MPM. High pre-treatment kep values suggest MPM disease control post-chemotherapy.